Kiadis’ proprietary off-the-shelf NK-cell platform is based on NK-cells from a unique universal donor.
Kiadis is focused on patient specific cell-based immunotherapy products for the treatment of life threatening diseases.
Kiadis has a pipeline of NK-cell therapies in development to treat blood cancer and solid tumors.
We always do the right thing:
- We put the patient first
- We are open and honest
- We help each other
- We act with a sense of urgency
- We deliver quality
Our uncompromising approach to serve patients, their families and care givers aims to minimize harm and maximize help – delivering personalized treatments for every single patient to offer hope, reduce suffering and provide new life.